CareWatch develops wearable health-monitoring devices and remote-monitoring software that give physicians and care teams real-time patient data from anywhere. Its system tracks vital information such as oxygen levels, heart rate, and movement, while sending alerts and feeding data into PointClickCare to support remote care and billing workflows. Founded by Chris Berry and led by a team spanning medical practice and software development, the company focuses on helping patients who may not always be able to advocate for themselves.
HIPAA Compliant
Compliance program
FDA Approved
FDA
Quality certification
LifeSignalsLifeSignals develops single-use wearable biosensors and cloud-based monitoring systems that capture and transmit clinical-grade patient data wirelessly, helping move care beyond the hospital bedside. Its UbiqVue platform combines a patented silicon processor with wearable devices and software for near-real-time multiparameter monitoring and Holter ECG services, while also supporting OEM integration. Founded by wireless technology engineers, the company works with global semiconductor and manufacturing partners to bring scalable monitoring to hospitals, homes, and ambulatory care.NEW YORK, NY
Health Care Originals, IncBorn from co-founder Sharon Samjitsingh’s experience with severe asthma, Rochester-based Health Care Originals develops cardiopulmonary wearable systems and the software that turns respiratory data into usable insight. Its ADAMM platform supports asthma and COPD care, telemedicine, and clinical research by tracking symptoms such as cough and breathing patterns between visits as well as during remote consultations. The company’s technology has received recognition including CES 2015 honors and Innovation World Cup awards.ROCHESTER, NY
LASARRUSFounded by four brothers with more than 50 years of combined professional experience, LASARRUS develops WearME, an AI-powered wearable and software system for continuous COPD monitoring and early detection. The company’s research-driven platform tracks physiological signals and gives clinicians actionable insight into changes in a patient’s condition. LASARRUS has won Intel’s 2018 design contest, received three SBIR grants, and been awarded four patents as it works toward FDA clearance.BALTIMORE, MD
AltruMedAltruMed develops DOVE, a discreet wearable device that detects early signs of opioid overdose and alerts nearby bystanders and emergency responders. Worn beneath clothing on the shoulder, the device uses noninvasive optical and motion sensors to monitor physiological changes associated with overdose. DOVE has received FDA Breakthrough Device designation and is being developed by a team spanning technology, medical, operations, and public-health expertise.PHILADELPHIA, PA